ArticleMediterranean journal of hematology and infectious diseases2015

Occurrence of secondary malignancies in chronic myeloid leukemia during therapy with imatinib mesylate-single institution experience.

Grzegorz Helbig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.